• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Med . Determining extent of COVID-19 pneumonia on CT based on biological variables

tetano

Editor, Senior Moderator
Respir Med


. 2020 Nov 5;175:106206.
doi: 10.1016/j.rmed.2020.106206. Online ahead of print.
Determining extent of COVID-19 pneumonia on CT based on biological variables


Tordjman Mickael[SUP] 1 [/SUP], Mekki Ahmed[SUP] 2 [/SUP], Mali D Rahul[SUP] 3 [/SUP], Monnier Hippolyte[SUP] 4 [/SUP], Neveu Sophie[SUP] 5 [/SUP], Chassagnon Guillaume[SUP] 6 [/SUP], Mihoubi Fadila[SUP] 5 [/SUP], Carlier Nicolas[SUP] 7 [/SUP], Marey Jonathan[SUP] 7 [/SUP], Fournier Laure[SUP] 8 [/SUP], Carlier Robert-Yves[SUP] 9 [/SUP], Drape Jean-Luc[SUP] 10 [/SUP], Revel Marie-Pierre[SUP] 10 [/SUP]



Affiliations

Abstract

Introduction: Covid-19 pneumonia CT extent correlates well with outcome including mortality. However, CT is not widely available in many countries. This study aimed to explore the relationship between Covid-19 pneumonia CT extent and blood tests variations. The objective was to determine for the biological variables correlating with disease severity the cut-off values showing the best performance to predict the parenchymal extent of the pneumonia.
Methods: Bivariate correlations were calculated between biological variables and grade of disease extent on CT. Receiving Operating Characteristic curve analysis determined the best cutoffs for the strongest correlated biological variables. The performance of these variables to predict mild (<10%) or severe pneumonia (>50% of parenchyma involved) was evaluated.
Results: Correlations between biological variables and disease extent was evaluated in 168 patients included in this study. LDH, lymphocyte count and CRP showed the strongest correlations (with 0.67, -0.41 and 0.52 correlation coefficient, respectively). Patients were split into a training and a validation cohort according to their centers. If one variable was above/below the following cut-offs, LDH>380, CRP>80 or lymphocyte count <0.8G/L, severe pneumonia extent on CT was detected with 100% sensitivity. Values above/below all three thresholds were denoted in 73% of patients with severe pneumonia extent. The combination of LDH<220 and CRP<22 was associated with mild pneumonia extent (<10%) with specificity of 100%.
Discussion: LDH showed the strongest correlation with the extent of Covid-19 pneumonia on CT. Combined with CRP?lymphocyte count, it helps predicting parenchymal extent of the pneumonia when CT scan is not available.

Keywords: CT-scan; Coronavirus 2019 disease; Leukocytes.
 
Back
Top Bottom